NCT07077655 Marmet and Oxytocin Massage for Breast Milk Increase
| NCT ID | NCT07077655 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ege University |
| Condition | Healhty |
| Study Type | INTERVENTIONAL |
| Enrollment | 123 participants |
| Start Date | 2025-08-25 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 123 participants in total. It began in 2025-08-25 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed as a randomized controlled single-blind experimental study to examine the effectiveness of the oxytocin massage and Marmet technique applied to mothers who have undergone cesarean section on breast milk quantity and maternal state anxiety levels. The hypotheses of the study are as follows: H0.1. There is no difference in the amount of breast milk among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups. H1.1. There is a difference in the amount of breast milk among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups. H0.2. There is no difference in the state anxiety scale scores among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups. H1.2. There is a difference in the state anxiety scale scores among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups. Participants: Marmet technique, oxytocin massage, and control (placebo) groups will be informed about the study and asked to provide their consent. Participants will complete the descriptive questionnaire. Colostrum status will be checked and marked as "present" or "absent" on the "Breast Milk, Vital Signs, and Pain Level Form." Under researcher supervision, the mother will breastfeed her baby. Afterward, the State Anxiety Inventory will be administered. Two hours later, mothers will express milk using a hospital-grade pump, with 15 minutes on each breast (total 30 minutes). Milk volume, vital signs, pain levels, and milk flow rate will be recorded on the relevant form. Following this, mothers in the Marmet group will receive 10 minutes of the Marmet technique, mothers in the oxytocin group will receive 5 minutes of oxytocin massage, and mothers in the control group will receive 5 minutes of light touch on their wrists and shoulders. Immediately after, milk expression will again be performed with 15 minutes per breast (30 minutes total). The State Anxiety Inventory will be re-administered, and milk amount, vital signs, pain levels, and flow rate will be recorded again. All mothers will express milk using a hospital-grade breast pump, and the expression duration is standardized as 15 minutes per breast (30 minutes total) based on the literature. Two expressions will be performed - one before and one immediately after the intervention. Expressed milk will not be discarded and will instead be used to feed the babies via spoon or syringe under the researcher's supervision.
Eligibility Criteria
Inclusion Criteria: * Aged between 18-35 years * Literate * Fluent in Turkish * Volunteering to participate in the study * Primiparous (first-time mothers) * Within the first 2 hours postpartum (mothers performing their first breastfeeding under researcher supervision) * Have a single baby with an appropriate birth weight for gestational age (\>2500 gr) * Have their baby with them * Received spinal anesthesia * Neither the mother nor the baby has any acute or chronic illness * Exclusively breastfeeding their baby * Had a term (37 weeks gestation or more) and cesarean delivery * Experienced no complications after the cesarean section * No issues preventing breastfeeding * Willing to breastfeed Exclusion Criteria: * Are under 18 or over 35 years old * Are multiparous (have given birth before) * Are encountered more than 2 hours postpartum * Received general anesthesia * Have any acute or chronic illness themselves or their baby * Have conditions requiring mother and baby to be separated * Report experiencing severe pain * Formula-feed their baby or consume any milk-increasing medication or tea * Gave birth before 37 weeks gestation or had a vaginal delivery * Have an anatomical breast issue (absence of nipple, inverted nipple) * Have swelling, ecchymosis, or wounds on their back (for the oxytocin massage group) * Have a baby with a congenital anomaly * Have an issue preventing breastfeeding * Have a psychological issue * Are unwilling to breastfeed
Contact & Investigator
Aysima YALÇINTEPE
PRINCIPAL INVESTIGATOR
Ege University
Frequently Asked Questions
Who can join the NCT07077655 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Healhty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07077655 currently recruiting?
Yes, NCT07077655 is actively recruiting participants. Contact the research team at aysima.ylcntepe@gmail.com for enrollment information.
Where is the NCT07077655 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT07077655 clinical trial?
NCT07077655 is sponsored by Ege University. The principal investigator is Aysima YALÇINTEPE at Ege University. The trial plans to enroll 123 participants.